Resveratrol alleviates lysophosphatidylcholine-induced damage and inflammation in vascular endothelial cells

  • Authors:
    • Jinsong Chen
    • Xiaocheng Cao
    • Yonghong Cui
    • Gaofeng Zeng
    • Jiaxian Chen
    • Guogang Zhang
  • View Affiliations

  • Published online on: December 18, 2017     https://doi.org/10.3892/mmr.2017.8300
  • Pages: 4011-4018
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

The role of resveratrol (trans-3,5,4'-trihydroxystilbene; RES) in lysophosphatidylcholine (LPC)‑induced injury and inflammation in endothelial cells (regarded as an early event in arteriosclerosis) is unclear. The present study investigated whether RES reduces lactate dehydrogenase (LDH) activity and secretion of inflammatory cytokines such asinterleukin‑6 and tumor necrosis factor‑α, via the Toll‑like receptor (TLR)‑4/myeloid differentiation primary response gene 88 (MyD88)/nuclear factor (NF)‑κB signal transduction pathway in LPC‑induced damage and inflammation in human umbilical vein endothelial‑12 (HUVE‑12) cells. Using an ELISA and western blotting, the present study investigated the effects of RES on LDH activity and cytokine secretion. The effects of TLR‑4 short hairpin (sh)RNA and TLR‑4 cDNA transfection on NF‑κB activation during LPC‑induced damage and inflammation was also investigated in HUVE‑12 cells. The results demonstrated that RES significantly inhibited the effect of LPC on enzyme activity, pro‑inflammatory cytokine secretion, and expression of TLR‑4, MyD88 and NF‑κBp65 expression. In addition, RES and TLR‑4 shRNA transfection suppressed LPC‑induced injury and inflammation by blocking the TLR‑4/MyD88/NF‑κB signaling pathway Conversely, transfection with TLR‑4 cDNA enhanced LPC‑induced injury and inflammation, which abrogated the protective effects of RES. These data suggested that RES significantly suppressed LPC‑induced damage and inflammation, via suppression of the TLR‑4/MyD88/NF‑κB signaling pathway, which may provide a new mechanistic evidence for the treatment of arteriosclerosis by RES.
View Figures
View References

Related Articles

Journal Cover

March-2018
Volume 17 Issue 3

Print ISSN: 1791-2997
Online ISSN:1791-3004

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Chen J, Cao X, Cui Y, Zeng G, Chen J and Zhang G: Resveratrol alleviates lysophosphatidylcholine-induced damage and inflammation in vascular endothelial cells. Mol Med Rep 17: 4011-4018, 2018.
APA
Chen, J., Cao, X., Cui, Y., Zeng, G., Chen, J., & Zhang, G. (2018). Resveratrol alleviates lysophosphatidylcholine-induced damage and inflammation in vascular endothelial cells. Molecular Medicine Reports, 17, 4011-4018. https://doi.org/10.3892/mmr.2017.8300
MLA
Chen, J., Cao, X., Cui, Y., Zeng, G., Chen, J., Zhang, G."Resveratrol alleviates lysophosphatidylcholine-induced damage and inflammation in vascular endothelial cells". Molecular Medicine Reports 17.3 (2018): 4011-4018.
Chicago
Chen, J., Cao, X., Cui, Y., Zeng, G., Chen, J., Zhang, G."Resveratrol alleviates lysophosphatidylcholine-induced damage and inflammation in vascular endothelial cells". Molecular Medicine Reports 17, no. 3 (2018): 4011-4018. https://doi.org/10.3892/mmr.2017.8300